Mark W Tenforde
Biographic Data
| ID | 6062102 |
|---|---|
| NAME | Mark W Tenforde |
| GIVEN NAMES | Mark W |
| FAMILY NAME | Tenforde |
| SIGNATURE | TENFORDE M W |
| AFFILIATIONS | Aaron M. Frutos, Shunte Moon, Catherine H. Bozio, Mark W. Tenforde, Matthew Biggerstaff, and Kelsey M. Sumner are with the Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA. Alison M. Binder and Margaret A. Dudeck are with the Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, CDC. Andrea J. Cool, Kingsley Iyawe, and Trevor Thompson are with Booz Allen Hamilton, At |
| ORCID | 0000-0002-8702-8393 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 3 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2020 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Evaluation of a Novel Data Source for National Influenza Surveillance: Influenza Hospitalization Data in the National Healthcare Safety Network, United States, September 2021–April 2024
Objectives. To evaluate the completeness and utility of influenza hospital data reported to the Centers for Disease Control and Prevention’s National Healthcare Safety Network (NHSN) from September 2021 to April 2024. Methods. Acute care and critical access hospitals in the United States reported daily numbers of new hospital admissions of patients with laboratory-confirmed influenza to NHSN during voluntary and mandatory reporting periods. To ev…
Vaccine Effectiveness Against Sars-CoV-2 Related Hospitalizations in People who had Experienced Homelessness or Incarceration – Findings from the Minnesota EHR Consortium
COVID-19 disproportionately affects people experiencing homelessness or incarceration. While homelessness or incarceration alone may not impact vaccine effectiveness, medical comorbidities along with social conditions associated with homelessness or incarceration may impact estimated vaccine effectiveness. COVID-19 vaccines reduce rates of hospitalization and death; vaccine effectiveness (VE) against severe outcomes in people experiencing homeles…
Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with Covid-19 in a Multistate Health Care Systems Network — United States, March–June 2020
Prolonged symptom duration and disability are common in adults hospitalized with severe coronavirus disease 2019 (COVID-19). Characterizing return to baseline health among outpatients with milder COVID-19 illness is important for understanding the full spectrum of COVID-19-associated illness and tailoring public health messaging, interventions, and policy. During April 15-June 25, 2020, telephone interviews were conducted with a random sample of …
No prominent works on this page.
Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with Covid-19 in a Multistate Health Care Systems Network — United States, March–June 2020
Prolonged symptom duration and disability are common in adults hospitalized with severe coronavirus disease 2019 (COVID-19). Characterizing return to baseline health among outpatients with milder COVID-19 illness is important for understanding the full spectrum of COVID-19-associated illness and tailoring public health messaging, interventions, and policy. During April 15-June 25, 2020, telephone interviews were conducted with a random sample of …
Vaccine Effectiveness Against Sars-CoV-2 Related Hospitalizations in People who had Experienced Homelessness or Incarceration – Findings from the Minnesota EHR Consortium
COVID-19 disproportionately affects people experiencing homelessness or incarceration. While homelessness or incarceration alone may not impact vaccine effectiveness, medical comorbidities along with social conditions associated with homelessness or incarceration may impact estimated vaccine effectiveness. COVID-19 vaccines reduce rates of hospitalization and death; vaccine effectiveness (VE) against severe outcomes in people experiencing homeles…
Evaluation of a Novel Data Source for National Influenza Surveillance: Influenza Hospitalization Data in the National Healthcare Safety Network, United States, September 2021–April 2024
Objectives. To evaluate the completeness and utility of influenza hospital data reported to the Centers for Disease Control and Prevention’s National Healthcare Safety Network (NHSN) from September 2021 to April 2024. Methods. Acute care and critical access hospitals in the United States reported daily numbers of new hospital admissions of patients with laboratory-confirmed influenza to NHSN during voluntary and mandatory reporting periods. To ev…
Confidence interval (2 works) · COVID-19 Clinical Research Studies (2 works) · Gerontology (2 works) · Health care (2 works) · Internal Medicine (2 works) · Medical record (2 works) · Medicine (2 works) · Public health (2 works) · Acute care (1 works) · Cohort (1 works)